30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jason Cole

Track

Insider profile

Currently holds a position at bluebird bio Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 34% 68% 82%
Transactions
28 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Legal Officer, Secretary bluebird bio Inc March 1, 2016 -
Senior Vice President, General Counsel, Secretary bluebird bio Inc March 1, 2014 - March 1, 2016
Executive Vice President - Corporate Development, General Counsel, Secretary EPIRUS Biopharmaceuticals Inc March 1, 2012 - March 5, 2014
Senior Vice President - Corporate Development, General Counsel, Secretary EPIRUS Biopharmaceuticals Inc Sept. 1, 2011 - March 1, 2012
Jason Cole's trades of bluebird bio Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-23 2022-08-19
S Sale
13,253 -41.3%
316.84
US$4,057,938 		13,253 -41.3% 316.84 US$4,057,938
2022-08-08 2022-08-04
S Sale
65,563 +10.1%
446.55
US$2,034,761 		65,563 +10.1% 446.55 US$2,034,761
2022-01-12 2022-01-11
S Sale
82,158 -19.3%
266.28
US$4,485,191 		82,158 -19.3% 266.28 US$4,485,191
2022-01-12 2022-01-10
S Sale
1,584 -0.8%
9.40
US$14,893 		1,584 -0.8% 9.40 US$14,893
2021-04-07 2021-04-05
S Sale
37 -0.1%
30.21
US$1,118 		37 -0.1% 30.21 US$1,118
2021-03-04 2021-03-02
S Sale
38 -0.1%
29.58
US$1,124 		38 -0.1% 29.58 US$1,124
2021-02-18 2021-02-17
S Sale
665 -1.4%
28.16
US$18,727 		665 -1.4% 28.16 US$18,727
2021-02-04 2021-02-02
S Sale
38 -0.1%
45.93
US$1,745 		38 -0.1% 45.93 US$1,745
2021-01-08 2021-01-06
S Sale
986 -2.9%
45.46
US$44,827 		986 -2.9% 45.46 US$44,827
2021-01-08 2021-01-06
S Sale
1,372 -3.9%
44.76
US$61,409 		1,372 -3.9% 44.76 US$61,409
2021-01-08 2021-01-05
S Sale
43 -0.1%
44.95
US$1,933 		43 -0.1% 44.95 US$1,933
2020-12-04 2020-12-02
S Sale
1 -0.0%
46.50
US$46 		1 -0.0% 46.50 US$46
2020-12-04 2020-12-02
S Sale
37 -0.1%
46.19
US$1,709 		37 -0.1% 46.19 US$1,709
2020-11-04 2020-11-02
S Sale
4 -0.0%
54.43
US$218 		4 -0.0% 54.43 US$218
2020-11-04 2020-11-02
S Sale
7 -0.0%
53.83
US$377 		7 -0.0% 53.83 US$377
2020-11-04 2020-11-02
S Sale
26 -0.1%
52.51
US$1,365 		26 -0.1% 52.51 US$1,365
2020-10-06 2020-10-02
S Sale
38 -0.1%
52.77
US$2,005 		38 -0.1% 52.77 US$2,005
2020-09-08 2020-09-03
S Sale
36 -0.1%
58.60
US$2,110 		36 -0.1% 58.60 US$2,110
2020-08-05 2020-08-03
S Sale
9 -0.0%
60.98
US$549 		9 -0.0% 60.98 US$549
2020-08-05 2020-08-03
S Sale
28 -0.1%
60.32
US$1,689 		28 -0.1% 60.32 US$1,689
2020-07-07 2020-07-02
S Sale
38 -0.1%
61.57
US$2,340 		38 -0.1% 61.57 US$2,340
2020-06-04 2020-06-02
S Sale
29 -0.1%
64.24
US$1,863 		29 -0.1% 64.24 US$1,863
2020-06-04 2020-06-02
S Sale
9 -0.0%
63.36
US$570 		9 -0.0% 63.36 US$570
2020-01-09 2020-01-07
S Sale
1,957 -7.2%
89.97
US$176,074 		1,957 -7.2% 89.97 US$176,074
2019-02-27 2019-02-25
PlS Planned sale
525 -1.9%
151.41
US$79,491 		525 -1.9% 151.41 US$79,491
2019-02-27 2019-02-25
PlS Planned sale
5,723 -17.5%
150.13
US$859,207 		5,723 -17.5% 150.13 US$859,207
2019-01-09 2019-01-07
S Sale
488 -2.4%
114.31
US$55,781 		488 -2.4% 114.31 US$55,781
2019-01-09 2019-01-07
S Sale
928 -4.3%
113.29
US$105,133 		928 -4.3% 113.29 US$105,133
2018-01-09 2018-01-05
S Sale
147 -0.7%
174.17
US$25,603 		147 -0.7% 174.17 US$25,603
2017-01-09 2017-01-05
S Sale
549 -5.5%
67.10
US$36,838 		549 -5.5% 67.10 US$36,838